Tobacco leaf

Generic Name: Tobacco leaf

Drug Type: Biotech

CAS Number: 8037-19-2

Unique Ingredient Identifier: 6YR2608RSU

Overview

Tobacco leaf allergenic extract is used in allergenic testing.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Title	Posted	Study ID	Phase	Status	Sponsor
Informing Oral Nicotine Pouch Regulations to Promote Public Health	2024/03/18	NCT06315881	Phase 2	Recruiting	Ohio State University Comprehensive Cancer Center
Examining the Impact of Nicotine Pouches in Rural Ohio and Ohio Appalachia	2023/02/15	NCT05730439	Early Phase 1	Active, not recruiting	Ohio State University Comprehensive Cancer Center
Combined and Separate Effects of Cannabis and Tobacco: Psychomotor, Subjective and Physiological Outcomes	2022/09/02	NCT05526196	Not Applicable	Recruiting	Centre for Addiction and Mental Health
Understanding the Impact of Cartridge-Based Electronic Cigarettes and Generated Aerosols on Cardiopulmonary Health	2022/01/20	NCT05199480	Early Phase 1	Completed	Virginia Commonwealth University
A Stepped Care Approach to Treating Tobacco Use in Rural Veterans	2020/08/06	NCT04501016	Phase 2	Not yet recruiting	Iowa City Veterans Affairs Medical Center
Preliminary Investigation of Novel Methods to Reduce Children's Secondhand Smoke Exposure	2013/09/05	NCT01935713	Not Applicable	Completed	University of Oklahoma
Novel Methods to Reduce Children's Secondhand Smoke Exposure II	2013/07/11	NCT01896518	Not Applicable	Completed	University of Oklahoma
Effectiveness of Using Tobacco Free Snuff in Reducing Negative Effects of Smokeless Tobacco Use	2005/09/22	NCT00218270	Phase 2	Completed	National Institute on Drug Abuse (NIDA)

FDA Drug Approvals

Approved Product	Manufacturer	NDC Code	Route	Strength	Effective Date
Leaf Tobacco	Antigen Laboratories, Inc.	49288-0583	SUBCUTANEOUS, INTRADERMAL	0.02 g in 1 mL	11/13/2009
Tobacco Leaf	Nelco Laboratories, Inc.	36987-2242	INTRADERMAL, SUBCUTANEOUS	0.05 g in 1 mL	12/11/2009
Leaf Tobacco	Antigen Laboratories, Inc.	49288-0581	SUBCUTANEOUS, INTRADERMAL	0.1 g in 1 mL	11/13/2009
Tobacco Leaf	Nelco Laboratories, Inc.	36987-2245	INTRADERMAL, SUBCUTANEOUS	0.025 g in 1 mL	12/11/2009
Tobacco Leaf	Nelco Laboratories, Inc.	36987-2239	INTRADERMAL, SUBCUTANEOUS	10000 [PNU] in 1 mL	12/11/2009
Tobacco Leaf	Nelco Laboratories, Inc.	36987-2240	INTRADERMAL, SUBCUTANEOUS	20000 [PNU] in 1 mL	12/11/2009
Bestmade Natural Products BM55	Bestmade Natural Products	82969-2055	ORAL	70 [hp_C] in 100 [hp_C]	1/24/2025
Tobacco Leaf	Nelco Laboratories, Inc.	36987-2244	INTRADERMAL, SUBCUTANEOUS	0.025 g in 1 mL	12/11/2009
Leaf Tobacco	Antigen Laboratories, Inc.	49288-0582	SUBCUTANEOUS, INTRADERMAL	0.05 g in 1 mL	11/13/2009
Good Mood Enhancer	King Bio Inc.	57955-9150	ORAL	10 [hp_X] in 59 mL	5/19/2025

EMA Drug Approvals

Approved Product	Authorization Holder	Status	Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product	Manufacturer	Approval Number	Dosage Form	Strength	Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product	Company	Approval Number	Drug Type	Dosage Form	Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product	Registration No.	Company	Licence No.	Strength	Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product	ARTG ID	Sponsor	Registration Type	Status	Registration Date
No TGA approvals found for this drug.

Health Canada Drug Approvals

Approved Product	Company	DIN	Dosage Form	Strength	Market Date
MEDIPLEX 695 - (8 10 14 18X) TAB	mediherb inc.	02116871	Tablet - Oral	8 X	12/19/1996
TRS COMPLEX DPS	thompson's homeopathic supplies ltd.	00760919	Drops - Oral	3 X / X	12/31/1987
R 77 DPS	dr reckeweg canada	02095645	Drops - Oral	4 D / ML	12/31/1994
TOBTOX	bio active canada ltd.	02233688	Liquid - Oral	12 X	5/26/1998
TABACUM CUC RH D3 - DROPS	weleda ag heilmittelbetriebe	02174006	Drops , Liquid - Oral	3 D / ML	4/9/1998
TABACUM DROPS D3-C1000	thompson's homeopathic supplies ltd.	00782009	Drops - Oral	3 D / D	12/31/1988
TOBACOPT	terra botanica products ltd.	02233374	Liquid - Oral	12 X	5/25/1998
NICOTIANA COMP	Wala-Heilmittel GmbH	02232722	Pellet , Liquid - Oral	9 D	4/10/1998
ENDANGITIN	dr reckeweg and co	00245518	Liquid - Oral	4 X / X	12/31/1972
TABACUM	dolisos canada inc.	02234741	Liquid , Granules , Globules - Oral	3 X	1/5/1998

CIMA AEMPS Drug Approvals

Approved Product	Company	Registration Number	Pharmaceutical Form	Prescription Type	Status
No CIMA AEMPS (Spain) approvals found for this drug.

Philippines FDA Drug Approvals

Approved Product	Company	License Number	Dosage Form	Strength	Approval Date
No Philippines FDA approvals found for this drug.

Saudi SFDA Drug Approvals

Approved Product	Company	License Number	Dosage Form	Strength	Approval Date
No Saudi SFDA approvals found for this drug.

Malaysia NPRA Drug Approvals

Approved Product	Company	Registration Number	Dosage Form	Strength	Approval Date
No Malaysia NPRA approvals found for this drug.

UK EMC Drug Information

Medicine Name	MA Holder	MA Number	Pharmaceutical Form	Active Ingredient	Authorization Date
No UK EMC drug information found for this drug.

Related News

Experts Highlight Critical Link Between Schizophrenia and Substance Use Disorders, Call for Integrated Treatment Approach

7 months ago

Up to 80% of patients with schizophrenia experience comorbid substance use disorders, particularly involving tobacco, alcohol, and cannabis, creating significant treatment challenges.

Help Us Improve

Your feedback helps us provide better drug information and insights.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.